Hevir N - Search Results

1

The Significance of the Sulfatase Pathway for Local Estrogen Formation in Endometrial Cancer.

Sinreih M, Knific T, Anko M, Hevir N, Vouk K, Jerin A, Frković Grazio S, Rižner TL. Sinreih M, et al. Among authors: hevir n. Front Pharmacol. 2017 Jun 23;8:368. doi: 10.3389/fphar.2017.00368. eCollection 2017. Front Pharmacol. 2017. PMID: 28690541 Free PMC article.

2

Expression of estrogen and progesterone receptors and estrogen metabolizing enzymes in different breast cancer cell lines.

Hevir N, Trošt N, Debeljak N, Rižner TL. Hevir N, et al. Chem Biol Interact. 2011 May 30;191(1-3):206-16. doi: 10.1016/j.cbi.2010.12.013. Epub 2010 Dec 21. Chem Biol Interact. 2011. PMID: 21182832

3

Aldo-keto reductases AKR1C1, AKR1C2 and AKR1C3 may enhance progesterone metabolism in ovarian endometriosis.

Hevir N, Vouk K, Sinkovec J, Ribič-Pucelj M, Rižner TL. Hevir N, et al. Chem Biol Interact. 2011 May 30;191(1-3):217-26. doi: 10.1016/j.cbi.2011.01.003. Epub 2011 Jan 11. Chem Biol Interact. 2011. PMID: 21232532

4

Disturbed expression of phase I and phase II estrogen-metabolizing enzymes in endometrial cancer: lower levels of CYP1B1 and increased expression of S-COMT.

Hevir N, Sinkovec J, Rižner TL. Hevir N, et al. Mol Cell Endocrinol. 2011 Jan 1;331(1):158-67. doi: 10.1016/j.mce.2010.09.011. Epub 2010 Sep 29. Mol Cell Endocrinol. 2011. PMID: 20887769

5

Altered expression of genes involved in progesterone biosynthesis, metabolism and action in endometrial cancer.

Sinreih M, Hevir N, Rižner TL. Sinreih M, et al. Among authors: hevir n. Chem Biol Interact. 2013 Feb 25;202(1-3):210-7. doi: 10.1016/j.cbi.2012.11.012. Epub 2012 Nov 27. Chem Biol Interact. 2013. PMID: 23200943

6

Disturbed estrogen and progesterone action in ovarian endometriosis.

Smuc T, Hevir N, Ribic-Pucelj M, Husen B, Thole H, Rizner TL. Smuc T, et al. Among authors: hevir n. Mol Cell Endocrinol. 2009 Mar 25;301(1-2):59-64. doi: 10.1016/j.mce.2008.07.020. Epub 2008 Aug 13. Mol Cell Endocrinol. 2009. PMID: 18762229

7

Correlation between erythropoietin receptor(s) and estrogen and progesterone receptor expression in different breast cancer cell lines.

Trošt N, Hevir N, Rižner TL, Debeljak N. Trošt N, et al. Among authors: hevir n. Int J Mol Med. 2013 Mar;31(3):717-25. doi: 10.3892/ijmm.2013.1231. Epub 2013 Jan 8. Int J Mol Med. 2013. PMID: 23314808

8

Demonstrating suitability of the Caco-2 cell model for BCS-based biowaiver according to the recent FDA and ICH harmonised guidelines.

Jarc T, Novak M, Hevir N, Rižner TL, Kreft ME, Kristan K. Jarc T, et al. Among authors: hevir n. J Pharm Pharmacol. 2019 Aug;71(8):1231-1242. doi: 10.1111/jphp.13111. Epub 2019 Jun 2. J Pharm Pharmacol. 2019. PMID: 31155721

9

Discovery of phosphatidylcholines and sphingomyelins as biomarkers for ovarian endometriosis.

Vouk K, Hevir N, Ribić-Pucelj M, Haarpaintner G, Scherb H, Osredkar J, Möller G, Prehn C, Rižner TL, Adamski J. Vouk K, et al. Among authors: hevir n. Hum Reprod. 2012 Oct;27(10):2955-65. doi: 10.1093/humrep/des152. Epub 2012 Aug 1. Hum Reprod. 2012. PMID: 22859507

10

Different Culture Conditions Affect Drug Transporter Gene Expression, Ultrastructure, and Permeability of Primary Human Nasal Epithelial Cells.

Kreft ME, Tratnjek L, Lasič E, Hevir N, Rižner TL, Kristan K. Kreft ME, et al. Among authors: hevir n. Pharm Res. 2020 Aug 20;37(9):170. doi: 10.1007/s11095-020-02905-w. Pharm Res. 2020. PMID: 32820417

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters